Ulta Beauty
ULTA
$492.14
-2.58%
Ulta Beauty, Inc. is the largest specialized beauty retailer in the United States, operating over 1,500 freestanding stores that offer a comprehensive assortment of cosmetics, fragrances, skin care, and hair care products, complemented by in-store salon services. The company's distinct competitive identity is built on its one-stop-shop destination model that combines mass and prestige brands under one roof, fostering customer loyalty and driving significant traffic. The current investor narrative is dominated by concerns over rising costs and margin pressure, as evidenced by a sharp stock decline following its Q4 2026 earnings report, which overshadowed top and bottom-line beats and has shifted focus to the company's ability to navigate inflationary pressures and maintain profitability.…
ULTA
Ulta Beauty
$492.14
Related headlines
Investment Opinion: Should I buy ULTA Today?
Rating & Thesis: Hold. ULTA is a high-quality company navigating a difficult transition, but near-term margin headwinds and technical weakness advise patience. The consensus analyst stance remains bullish (Overweight/Buy), betting on a margin recovery, but the stock's reaction to its Q4 beat suggests the market needs proof.
Supporting Evidence: The valuation presents a mixed picture: the forward P/E of 16.83x is reasonable for a market leader, but the trailing P/E of 25.17x and PEG ratio of 22.87 are elevated, indicating high growth expectations. Revenue growth remains positive at 11.78% YoY, and the balance sheet is strong with a D/E of 0.78. However, the critical evidence is negative: net margin compression of 213 bps YoY and a severe -27.83% maximum drawdown with significant underperformance vs. the S&P 500.
Risks & Conditions: The two biggest risks are 1) further gross margin erosion below 38%, and 2) revenue growth decelerating into single digits. This Hold would upgrade to a Buy if the stock stabilizes above $500 and shows sequential margin improvement in the next quarterly report. It would downgrade to a Sell if Q4 margin compression proves not to be an anomaly and the stock breaks below its 52-week low. Currently, the stock is fairly valued relative to its challenged near-term prospects but undervalued relative to its long-term franchise value.
Sign up to view all
ULTA 12-Month Price Forecast
The AI assessment is neutral based on a clash between a deteriorating near-term fundamental picture (margins) and a still-strong long-term business model and financial position. The high forward earnings estimate of $43.01 suggests analysts see a path to recovery, but the market is rightfully skeptical until proven. Confidence is medium due to the high uncertainty around the trajectory of input costs and consumer demand. The stance would upgrade to bullish on clear evidence of margin stabilization (gross margin >39%) and downgrade to bearish on a break below the $500 support level on high volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $639.79 and implied upside of +30.0% versus the current price.
Average Target
$639.79
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$394 - $640
Analyst target range
Analyst coverage for ULTA appears limited in the provided dataset, with only 5 analysts contributing to EPS estimates, suggesting institutional coverage may be more extensive than shown. The consensus leans bullish, as evidenced by recent institutional ratings from March 2026 where major firms like Morgan Stanley, JP Morgan, and Piper Sandler maintained 'Overweight' or 'Buy' ratings, while Wells Fargo maintained an 'Underweight'. The average EPS estimate for the coming period is $43.01, with a range from $42.11 to $43.84, indicating a tight clustering of expectations and relatively high conviction in the near-term earnings outlook. The wide dispersion in price targets is not provided, but the maintained bullish stance by most analysts following the Q4 report suggests they view the post-earnings sell-off as an overreaction, betting on the company's long-term competitive position and margin recovery potential.
Bulls vs Bears: ULTA Investment Factors
The investment debate for ULTA is currently balanced but leans bearish in the near term due to overwhelming evidence of margin pressure and technical breakdown. The bull case rests on the company's strong financial health, dominant market position, and the attractive discount embedded in its forward earnings multiple. The bear case is driven by concrete, worsening profitability metrics and severe stock price underperformance. The single most important tension is whether management can successfully navigate inflationary cost pressures to stabilize and eventually expand margins. The resolution of this margin trajectory will determine if the stock's decline is a buying opportunity or the start of a prolonged de-rating.
Bullish
- Strong Free Cash Flow & ROE: ULTA generates robust free cash flow of $985.6M TTM, providing significant financial flexibility for growth and shareholder returns. The company's Return on Equity of 41.14% is exceptionally high, indicating efficient use of shareholder capital.
- Healthy Balance Sheet: The company maintains a solid financial position with a current ratio of 1.41 and a manageable debt-to-equity ratio of 0.78. This low leverage provides a cushion against economic downturns and operational challenges.
- Analyst Conviction in Earnings: Analyst EPS estimates for the coming period are tightly clustered around $43.01, with a narrow range from $42.11 to $43.84. This high conviction suggests a reliable near-term earnings floor, despite market volatility.
- Attractive Forward Valuation: The forward P/E of 16.83x represents a significant discount to the trailing P/E of 25.17x, implying the market expects a strong earnings recovery. This forward multiple prices in current margin concerns while offering upside if execution improves.
Bearish
- Severe Margin Compression: Q4 net margin compressed to 9.15% from 11.28% a year ago, and gross margin fell to 38.06% from 38.24%. This clear trend of rising cost pressures is the primary driver of the stock's recent 17.83% three-month decline.
- Technical Downtrend & Underperformance: The stock is in a pronounced downtrend, underperforming the S&P 500 by -21.97% over three months and trading near 74% of its 52-week range. A sustained break below $500 could accelerate selling toward the 52-week low of $386.
- Revenue Growth Deceleration: Q4 revenue growth of 11.78% YoY, while positive, represents a slowdown from stronger prior quarters. This deceleration raises questions about the sustainability of top-line momentum in a potentially weakening consumer environment.
- High Valuation Multiples: Despite the recent sell-off, ULTA trades at a trailing P/E of 25.17x and a Price/Book of 10.35x. These elevated multiples leave little room for error and make the stock vulnerable to further multiple compression if growth slows.
ULTA Technical Analysis
The stock is in a pronounced downtrend, having declined 17.83% over the past three months and 14.21% year-to-date, despite a strong 35.38% gain over the past year. With a current price of $531.95, ULTA is trading at approximately 74% of its 52-week range, positioned closer to the $386.00 low than the $714.97 high, suggesting the stock is in a corrective phase after a significant prior rally and may be approaching a potential value zone. Recent momentum is decisively negative, with the stock down 0.87% over the past month and 17.83% over three months, starkly diverging from the positive 1-year trend and indicating a significant near-term reversal, further evidenced by a severe -27.83% maximum drawdown and underperformance relative to the S&P 500 by -21.97% over three months. Key technical support is anchored at the 52-week low of $386.00, while resistance lies at the recent highs near $714.97; a sustained break below the $500 psychological level could accelerate selling toward the 52-week low, whereas a recovery above the $600 level is needed to signal trend stabilization. The stock's beta of 0.953 indicates volatility roughly in line with the broader market, but the recent sharp drawdown highlights idiosyncratic risk related to earnings sentiment.
Beta
0.89
0.89x market volatility
Max Drawdown
-30.4%
Largest decline past year
52-Week Range
$403-$715
Price range past year
Annual Return
+19.4%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | +8.2% |
| 3m | -26.2% | +9.0% |
| 6m | -7.0% | +10.5% |
| 1y | +19.4% | +26.5% |
| ytd | -20.6% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Revenue growth remains positive but shows signs of deceleration; the most recent Q4 revenue of $3.90 billion grew 11.78% year-over-year, a slowdown from the stronger growth rates seen in prior quarters, with the Retail Stores segment ($1.74B) and E-Commerce ($294.3M) being the primary drivers, while the Salon segment ($77.2M) remains a smaller traffic driver. The company is profitable with a Q4 net income of $356.7 million, but profitability metrics are under pressure, as the quarterly net margin of 9.15% and gross margin of 38.06% have compressed from the 11.28% net margin and 38.24% gross margin reported in the year-ago Q4, indicating rising cost pressures. The balance sheet is healthy with a current ratio of 1.41 and a debt-to-equity ratio of 0.78, while the company generates robust cash flow, evidenced by trailing twelve-month free cash flow of $985.6 million and an ROE of 41.14%, providing ample internal funding for growth and shareholder returns via buybacks.
Quarterly Revenue
$3.9B
2026-01
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$985555000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 25.17x, while the forward P/E is significantly lower at 16.83x, indicating the market expects a substantial earnings recovery in the coming year. Compared to sector averages, ULTA's trailing P/E of 25.17x and Price/Sales of 2.34x are not directly comparable without a provided industry benchmark, but the forward P/E discount suggests the market has already priced in near-term profitability challenges. Historically, the current trailing P/E of 25.17x is below the stock's own recent historical highs seen in early 2023 (over 19x forward) but above the lows seen during periods of stress, placing it in a mid-range that reflects a balance between growth expectations and current margin concerns.
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary risk is sustained margin compression, as evidenced by the Q4 net margin decline of 213 basis points year-over-year to 9.15%. This pressure stems from rising costs, which if persistent, could erode the company's high ROE of 41.14% and robust FCF generation of $985.6M. Furthermore, revenue growth decelerating to 11.78% YoY introduces top-line risk; should this slow further, the company's premium valuation multiples would be unjustified. The balance sheet is a mitigant, with low debt (D/E of 0.78), but the business model remains exposed to wage inflation and supply chain costs.
Market & Competitive Risks: Valuation compression is a significant threat, with the stock trading at a trailing P/E of 25.17x and a P/B of 10.35x. These multiples are high for a retailer and are vulnerable to de-rating if earnings growth falters. Competitive risks are omnipresent in retail, though ULTA's unique mass-and-prestige model provides some insulation. Macro risks are heightened, as the stock's beta of 0.95 indicates near-market correlation, and recent news on stagflation fears directly threatens consumer cyclical spending. The impending end of the Target partnership in summer 2026 also presents a future revenue headwind.
Worst-Case Scenario: The worst-case involves a recessionary environment where consumer spending on beauty contracts sharply, coinciding with unrelenting cost inflation. This would lead to consecutive quarters of margin misses and guidance cuts, triggering a wave of analyst downgrades. The stock could re-test its 52-week low of $386, representing a downside of approximately -27% from the current price of $531.95. A break below that level could see the stock fall toward a forward P/E of 12-14x, implying a price in the $350s, for a total peak-to-trough drawdown exceeding -35%.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Sustained margin compression, as seen in Q4 with net margin falling to 9.15%. 2) Valuation Risk: High multiples (P/E 25.2x) could compress further if growth slows. 3) Macroeconomic Risk: As a consumer cyclical stock (beta 0.95), it is sensitive to recession and stagflation fears which threaten spending. 4) Competitive/Strategic Risk: The end of the lucrative Target partnership in 2026 creates a future revenue headwind that must be offset.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $530 and $600 as margins stabilize and earnings meet the $43.01 consensus. The Bull Case (30% probability) targets $650 to $715 on successful cost management and a valuation re-rating. The Bear Case (20% probability) warns of a drop to $386-$480 if margin pressure intensifies and consumer spending weakens. The base case is most likely, hinging on the assumption that Q4 represented a margin trough, not a new trend.
ULTA's valuation is fair to slightly overvalued relative to its current challenged fundamentals but potentially undervalued relative to its long-term potential. The trailing P/E of 25.2x and Price/Book of 10.4x are high for a retailer facing margin pressure. However, the forward P/E of 16.8x implies the market expects a meaningful earnings rebound, pricing in the current troubles. Compared to its own history, the stock is in a mid-range valuation. The market is paying a fair price for a company in transition, but it is not a deep value opportunity unless margins recover as anticipated.
ULTA is a good stock for patient, long-term investors who can accept near-term volatility, but it is not a clear-cut buy today. The 27% decline from its high has improved the valuation, with a forward P/E of 16.8x. However, the sharp margin compression and technical breakdown indicate significant near-term risk. It could be a good buy for investors who believe management will successfully navigate cost pressures, but they should be prepared for further downside, potentially to the $386 low, if conditions worsen. A staggered entry or waiting for margin stabilization is prudent.
ULTA is primarily suitable for a long-term investment horizon of 3-5 years. The company's strong franchise, healthy balance sheet, and high ROE are long-term assets, but the near-term path is clouded by margin uncertainty and technical weakness. The stock's beta of 0.95 and lack of a dividend make it less ideal for short-term trading or income-seeking investors. Given the current setup, a minimum holding period of 12-18 months is suggested to allow the margin recovery thesis to play out and for the technical chart to potentially repair itself.